Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Cinacalcet attenuates hypercalcemia observed in mice bearing either Rice H-500 Leydig cell or C26-DCT colon tumors.

Colloton M, Shatzen E, Wiemann B, Starnes C, Scully S, Henley C, Martin D.

Eur J Pharmacol. 2013 Jul 15;712(1-3):8-15. doi: 10.1016/j.ejphar.2013.04.013. Epub 2013 Apr 23.

PMID:
23623934
2.

Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.

Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.

Clin Cancer Res. 2005 Jun 1;11(11):4198-203.

3.

Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.

Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA.

Cancer Res. 1997 Aug 1;57(15):3194-9.

4.

Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy.

Tfelt-Hansen J, Chattopadhyay N, Yano S, Kanuparthi D, Rooney P, Schwarz P, Brown EM.

Endocrinology. 2004 Mar;145(3):1211-7. Epub 2003 Nov 26.

PMID:
14645111
5.

Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.

Sato K, Onuma E, Yocum RC, Ogata E.

Semin Oncol. 2003 Oct;30(5 Suppl 16):167-73. Review.

PMID:
14613038
7.

Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.

Sato K, Yamakawa Y, Shizume K, Satoh T, Nohtomi K, Demura H, Akatsu T, Nagata N, Kasahara T, Ohkawa H, et al.

J Bone Miner Res. 1993 Jul;8(7):849-60.

PMID:
8352067
8.

Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.

Brown GM, Morris CA, Mitnick MA, Insogna KL.

J Bone Miner Res. 1990 Oct;5(10):1037-41.

PMID:
1964358
9.
11.

Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide.

Rabbani SA, Gladu J, Liu B, Goltzman D.

Endocrinology. 1995 Dec;136(12):5416-22.

PMID:
7588290
12.
13.
14.
15.

Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl.

Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, Van Wagenen BC, Colloton M, Karbon W, Scherrer J, Shatzen E, Rishton G, Scully S, Qi M, Harris R, Lacey D, Martin D.

J Pharmacol Exp Ther. 2004 Feb;308(2):627-35. Epub 2003 Oct 30.

16.
18.

Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.

Yaghoobian J, Morieux C, Denne MA, Bouizar Z, Ureña P, de Vernejoul MC.

Horm Metab Res. 1998 May;30(5):249-55.

PMID:
9660083
19.

Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.

Syed MA, Horwitz MJ, Tedesco MB, Garcia-Ocaña A, Wisniewski SR, Stewart AF.

J Clin Endocrinol Metab. 2001 Apr;86(4):1525-31.

PMID:
11297578

Supplemental Content

Support Center